Cargando…
Diphthamide-deficiency syndrome: a novel human developmental disorder and ribosomopathy
We describe a novel type of ribosomopathy that is defined by deficiency in diphthamidylation of translation elongation factor 2. The ribosomopathy was identified by correlating phenotypes and biochemical properties of previously described patients with diphthamide biosynthesis gene 1 (DPH1) deficien...
Autores principales: | Hawer, Harmen, Mendelsohn, Bryce A., Mayer, Klaus, Kung, Ann, Malhotra, Amit, Tuupanen, Sari, Schleit, Jennifer, Brinkmann, Ulrich, Schaffrath, Raffael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575589/ https://www.ncbi.nlm.nih.gov/pubmed/32576952 http://dx.doi.org/10.1038/s41431-020-0668-y |
Ejemplares similares
-
Importance of diphthamide modified EF2 for translational accuracy and competitive cell growth in yeast
por: Hawer, Harmen, et al.
Publicado: (2018) -
Yeast gene KTI13 (alias DPH8) operates in the initiation step of diphthamide synthesis on elongation factor 2
por: Arend, Meike, et al.
Publicado: (2023) -
Translational fidelity and growth of Arabidopsis require stress-sensitive diphthamide biosynthesis
por: Zhang, Hongliang, et al.
Publicado: (2022) -
DPH1 and DPH2 variants that confer susceptibility to diphthamide deficiency syndrome in human cells and yeast models
por: Ütkür, Koray, et al.
Publicado: (2023) -
DPH1 Gene Mutations Identify a Candidate SAM Pocket in Radical Enzyme Dph1•Dph2 for Diphthamide Synthesis on EF2
por: Ütkür, Koray, et al.
Publicado: (2023)